Randox Showcases Pioneering Diagnostic Technologies at 2021 AACC Clinical Lab Expo
By LabMedica International staff writers Posted on 28 Sep 2021 |
Randox Laboratories (Crumlin, UK) showcased its pioneering diagnostic technologies at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, which saw breakthrough innovations shaping the future of clinical testing and patient care.
With more than 400 companies exhibiting, the 2021 AACC Clinical Lab Expo is the premier global laboratory medicine exposition. Among its diverse product range displayed at AACC 2021 were third party quality control solutions, diagnostic reagents which included many niche & superior performance assays, clinical chemistry analyzers, molecular diagnostic solutions for infectious diseases including COVID-19 and patented biochip technology. The revolutionary biochip is capable of simultaneously detecting hundreds of targets from a single patient sample. Complete patient profiling in this way facilitates faster patient testing, earlier diagnosis and improved patient pathways.
Randox also demonstrated its Qnostics range of molecular controls for infectious diseases comprising hundreds of characterized viral, bacterial and fungal targets covering a wide range of diseases and infections. Comprising hundreds of characterized viral, bacterial and fungal targets, the Qnostics range includes transplant associated diseases, respiratory diseases, blood borne viruses, sexually transmitted infections, gastrointestinal infections and central nervous system diseases. The products can be used in the daily monitoring of assay performance, linearity assessment, assay evaluation, validation and verification of new assays and staff training.
Also on display at the event were the company’s Acusera Anti-SARS-CoV-2 controls which support assay validation and routine performance monitoring of serological assays for COVID-19. Conveniently supplied in a liquid format, this control has unrivalled 30-day open vial stability, therefore keeping waste to a minimum.
Related Links:
Randox Laboratories
Latest Hematology News
- Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
- First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
- POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
- First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
- Handheld White Blood Cell Tracker to Enable Rapid Testing For Infections
- Smart Palm-size Optofluidic Hematology Analyzer Enables POCT of Patients’ Blood Cells
- Automated Hematology Platform Offers High Throughput Analytical Performance
- New Tool Analyzes Blood Platelets Faster, Easily and Accurately
- First Rapid-Result Hematology Analyzer Reports Measures of Infection and Severity at POC
- Bleeding Risk Diagnostic Test to Reduce Preventable Complications in Hospitals
- True POC Hematology Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput
- Blood Test Could Predict Outcomes in Emergency Department and Hospital Admissions
- Novel Technology Diagnoses Immunothrombosis Using Breath Gas Analysis
- Advanced Hematology System Allows Labs to Process Up To 119 Complete Blood Count Results per Hour
- Unique AI-Based Approach Automates Clinical Analysis of Blood Data